The low GSN expression in colon cancer tissues is a favorable factor that improves the prognosis of colon cancer patients (Kim et al., 2018; Chen et al., 2019a) due to the silencing of GSN impedes colorectal cancer cell migration and invasiveness and induces cell cycle stagnation (Huang et al., 2022). The gene discussed is GSN; the disease is colorectal cancer.